RxDoctor Payments Data

Barnabas Hines, DO

Family Medicine · Johnson City, TNNPI 1114267119

Payments from drug & device makers

$10,528in general payments, 2019–2025

Across 730 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$1K
  • AstraZeneca$870
  • Lilly USA, LLC$779
  • Novo Nordisk$758
  • Pfizer$606
  • plus $5K from 45 others

What the payments were for

  • Food & beverage$10,514100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,528 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$81,813
Medicare patients
136
Services billed
2,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban93$82,798
OzempicSemaglutide60$64,083
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$56,961
TrulicityDulaglutide44$51,451
FarxigaDapagliflozin Propanediol45$47,156
Tresiba Flextouch U-200Insulin Degludec18$43,165
JardianceEmpagliflozin43$37,795
MounjaroTirzepatide33$36,470
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$29,572
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$17,653
LinzessLinaclotide18$15,109
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$12,997
Novolog FlexpenInsulin Aspart23$12,053
GlyxambiEmpagliflozin/Linagliptin12$10,806
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen284$8,594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$779$87,92177 claims
PfizerEliquis$606$82,79893 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$870$79,68988 claims
Novo NordiskOzempic$758$64,08360 claims
Boehringer IngelheimJardiance, Glyxambi, Combivent Respimat$273$53,98966 claims
GSKTrelegy Ellipta$1,064$29,57232 claims
AbbVieLinzess, Synthroid$1,670$18,84449 claims
MerckJanuvia$32$6,69411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →